NCT01855256View on ClinicalTrials.gov

Treatment of Hyperhidrosis With Oxybutynin

PHASE3CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

February 28, 2014

Study Completion Date

March 31, 2014

Conditions
Hyperhidrosis
Interventions
DRUG

Oxybutynin

Oxybutynin is started at a dose of 2.5 mg / day and increased gradually until an effective dose without exceed 7.5 mg / day up to 6 weeks.

DRUG

Placebo

Placebo is started at a dose of 2.5 mg / day and increased gradually until an effective dose without exceed 7.5 mg / day up to 6 weeks.

Trial Locations (4)

29000

Dermatologist'S Office, Quimper

29600

CHG de Morlaix, Morlaix

29609

Hospital, Brest, Brest

29800

CHG Landerneau, Landerneau

All Listed Sponsors
collaborator

Ministry of Health, France

OTHER_GOV

lead

University Hospital, Brest

OTHER

NCT01855256 - Treatment of Hyperhidrosis With Oxybutynin | Biotech Hunter | Biotech Hunter